✦ LIBER ✦

Multicenter clinical trial of 22-oxa-1,25-dihydroxyvitamin D3 for chronic dialysis patients

✍ Scribed by Masako Yasuda; Takashi Akiba; Hiroshi Nihei

Book ID: 114463974
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 82 KB
Volume: 41
Category: Article
ISSN: 0272-6386
DOI: 10.1053/ajkd.2003.50097

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Affinity of 22-oxa-1,25(OH)2D3 for 1,25-

Affinity of 22-oxa-1,25(OH)2D3 for 1,25-dihydroxyvitamin D receptor and its effects on the synthesis of osteocalcin in human osteosarcoma cells

✍ Teija Valaja; Anitta Mahonen; Asta Pirskanen; Pekka H. Mäenpää 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 564 KB

Attenuated up-regulation of vitamin D-de

Attenuated up-regulation of vitamin D-dependent calcium-binding proteins by 22-oxa-1,25-dihydroxyvitamin D3 in uremic rats: A possible mechanism for less-calcemic action

✍ Fumihiko ICHIKAWA; Michinori HIRATA; Koichi ENDO; Kyoko KATSUMATA; Hiroyuki OHKA 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 448 KB

Bendamustine in Combination With Rituxim

Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

✍ Fischer, K.; Cramer, P.; Busch, R.; Bottcher, S.; Bahlo, J.; Schubert, J.; Pflug 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 156 KB

Efficacy of peginterferon ALFA-2A (40KD)

Efficacy of peginterferon ALFA-2A (40KD) (PEGASYS) plud ribavirin for 24 weeks in genotype 1 patients with chronic hepatitis C followed by mono or combination therapy for 22 weeks: Preliminary analysis of an open, multicenter, randomized trial

✍ J.P. Bronowicki; D. Ouzan; T. Asselah; H. Desmorat; J.P. Zarski; J. Foucher; M. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 278 KB

Multicenter phase II clinical trial of n

Multicenter phase II clinical trial of nilotinib for patients with imatinib-resistant or -intolerant chronic myeloid leukemia from the East Japan CML study group evaluation of molecular response and the efficacy and safety of nilotinib

✍ Takahashi, Naoto; Miura, Masatomo; Kuroki, Jun; Mitani, Kinuko; Kitabayashi, Ats 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 344 KB